Induced Myerosuppression And Recommendation For Monitoring Of Absolute Neutrophil Counts In Patients Treated With Epirubicin And Cyclophosphamide In Early Breast Cancer: Results From A Phase 2a Collaborative Trial Of The Ago-B And Cesar Study Groups
BLOOD（2018）
摘要
Introduction
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要